Danish Diabetes Academy
Danish Diabetes Academy
Odense C, Denmark

Danish Diabetes Academy

Diabetes mellitus – both type 1 diabetes (T1D) and type 2 diabetes (T2D) - is a widespread disease increasing rapidly worldwide. The prevalence increases with around 5 % per year and is close to 10 % for adults. In Denmark we are approaching 300,000 diabetics, thus creating a great challenge – both socioeconomically and medically.

The Danish Diabetes Academy was established September 1, 2012. The Academy is financed by a 5-year grant from the Novo Nordisk Foundation and co-financed by JDRF (the Juvenile Diabetes Research Foundation), University of Southern Denmark, University of Copenhagen, Aarhus University and the University Hospitals of Odense, Aarhus and Copenhagen. The Academy is the first of its kind in Denmark and will occupy around 300 researchers during the first 5 years. The Academy constitutes an original platform for a national diabetes research strategy that is rational and science-based, and which will ensure both basic and clinical research in diabetes. The Academy is expected to foster enhanced collaboration between Danish diabetes research environments and ensure rapid distribution and shared access to novel research results, ideas and technologies, thus benefitting other research groups within the organisation.